Notice of an Extra-Ordinary General Meeting of the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemant Surgical Industries has called an EGM on August 30, 2025, via video conferencing, to seek shareholder approval for three key items. First, the company plans to increase its authorised share capital from Rs. 10.5 crore (1.05 crore equity shares) to Rs. 16 crore (1.6 crore equity shares of Rs. 10 each). Second, it proposes to issue up to 21 lakh convertible warrants at Rs. 197 each (a premium of Rs. 187), potentially raising up to Rs. 41.37 crore, with allottees including Singularity AIFs (non-promoters) and three promoter-group individuals. Third, it proposes to issue up to 26 lakh equity shares directly at Rs. 197 each, raising up to Rs. 51.22 crore from 12 non-promoter allottees including AIFs, corporates, and individuals. The total potential capital raise across both preferential issues is approximately Rs. 92.59 crore. Promoters are contributing Rs. 11.82 crore through warrants, showing their commitment. The issue price of Rs. 197 is marginally above the SEBI-determined minimum price of Rs. 196.16.
Existing shareholders will face significant dilution if all warrants are converted and equity shares are issued, with the share count potentially expanding by up to 47 lakh shares (~45% of current equity). The sizeable capital raise suggests the company is preparing for a major growth initiative or expansion, though specifics on use of funds are not disclosed in this notice. Promoter participation signals confidence, but retail investors should watch for the explanatory statement that will follow and assess dilution impact and funding purpose.